Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
Financial Results:
Lincoln Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹136.00 Crores up from ₹123.00 Crore year on year, a rise of 10.57%.
Total Expenses for Q1FY24 of ₹118.00 Crores up from ₹109.00 Crores year on year, a rise of 8.26%.
Consolidated Net Profit of ₹19.00 Crores up 26.67% from ₹15.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹9.49, up 26.70% from ₹7.49 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.